Novartis Investigative Site

Estado de México 52787

0 studies enrolling now · 2 studies all time

What they study most

Cytokine Storm (Covid-19), Leukemia, Myelomonocytic, Chronic, Myelodysplastic Syndromes

Studies at this site

• Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2) — Stopped early
• Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm — Completed